Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD98 is a multifunctional cell surface glycoprotein, best known as the heavy chain component of heterodimeric amino acid transporters, particularly the large neutral amino acid transporter (LAT1). It plays a crucial role in amino acid transport, cell adhesion, integrin signaling, and immune regulation. It is overexpressed in various cancers and is a target for antibody-based therapies.
Targeted therapies using anti-CD98 antibodies are under investigation. pH-dependent antibody variants enhance tumor-specific activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD98 heavy chain (CD98hc).